AQK-41861-43180
3 vaccinations
7 coded responses
25 check-ins
6 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 980 / WA
- Registered
- 2021-05-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-07
Registered in v-safe
-
2021-05-07
Dose 1 — Pfizer-BioNTech
-
2021-05-08
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-05-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-05-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-12
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-13
Survey response — days 1–6 daily, dose 1MedDRA: Cough — Feeling: Good · Headache, Muscle or body achesFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-14
- 2021-05-21
-
2021-05-28
Survey response — day 21, dose 1MedDRA: Insomnia, Lethargy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Lethargy. Bit of insomnia as well.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-01
Dose 2 — Pfizer-BioNTech
-
2021-06-01
Health check-in — day 0, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
-
2021-06-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Abdominal painAdult check-in
-
2021-06-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-06-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-06-06
- 2021-06-08
-
2021-06-15
Survey response — day 14, dose 2MedDRA: Anxiety, Restlessness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Restlessness with mild anxiety.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-22
- 2021-06-29
- 2021-07-06
- 2021-07-13
-
2021-08-31
Survey response — 3 months, dose 2MedDRA: Abdominal pain upper, Diarrhoea haemorrhagic, Fatigue, Headache, Insomnia, Oropharyngeal pain, Unevaluable event — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Sore throat, difficulty sleeping/excessive tiredness, stomach pain & diarrhea w/blood, headachewhich are attributable to a recent new medication. · Healthcare visit (other): Blood tests (CBC, liver function)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-31
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-11-30
Survey response — 6 months, dose 2MedDRA: Oropharyngeal pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sore throat, lingering 2 weeks in November.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-30
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-01
- 2021-12-06
-
2022-01-12
Dose 3 — Pfizer-BioNTech
-
2022-07-15
Survey response — 6 months, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodFree text: Positive sleep myoclonus with symptom onset last year and persisting several months. Noticed recurrence over the last two to three weeks; current presentation is less severe.MedDRA releases: 2024-11 · check-in free text available
-
2023-01-12
Survey response — 12 months, dose 3MedDRA: Dyspnoea, Myoclonus, Nausea, Neurological symptom, Pneumonia influenzal, Pyrexia, Tachycardia, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-12
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-13
- 2023-01-13
- 2023-01-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-07 | Pfizer-BioNTech | |
| 2 | 2021-06-01 | Pfizer-BioNTech | |
| 3 | 2022-01-12 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Cough
Release 8 — day 21, dose 1
Symptoms: Lethargy. Bit of insomnia as well.
Release 9 — day 14, dose 2
Symptoms: Restlessness with mild anxiety.
Release 9 — 3 months, dose 2
Symptoms: Sore throat, difficulty sleeping/excessive tiredness, stomach pain & diarrhea w/blood, headachewhich are attributable to a recent new medication.
Healthcare visit (other): Blood tests (CBC, liver function)
Release 10 — 6 months, dose 2
Symptoms: Sore throat, lingering 2 weeks in November.
Release 12 — 6 months, dose 3
Symptoms: Positive sleep myoclonus with symptom onset last year and persisting several months. Noticed recurrence over the last two to three weeks; current presentation is less severe.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | · | ✓ |
| SD | Abdominal pain upper | ✓ | · | ✓ |
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Diarrhoea haemorrhagic | ✓ | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Lethargy | ✓ | ✓ | ✓ |
| SD | Myoclonus | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Neurological symptom | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Pneumonia influenzal | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Restlessness | ✓ | ✓ | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release